Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_4
1
20%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (40.0%)
Phase 41 (20.0%)
N/A2 (40.0%)

Trials by Status

recruiting120%
completed360%
terminated120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_4

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

NCT06726395
completednot_applicable

Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia

NCT03248063
completedphase_3

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

NCT01792804
terminatedphase_3

Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.

NCT01875263
completednot_applicable

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

NCT00885300

Clinical Trials (5)

Showing 5 of 5 trials
NCT06726395Phase 4

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Recruiting
NCT03248063Not Applicable

Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia

Completed
NCT01792804Phase 3

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

Completed
NCT01875263Phase 3

Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.

Terminated
NCT00885300Not Applicable

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5